A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata
Epistemonikos ID: c5e4e52e473cd2554d267ef130a0523346694740
First added on: May 10, 2024